AGN News and Press, Allergan plc From 05/06/20

In June 2019, AbbVie (NYSE: ABBV) announced it would acquire Allergan (NYSE: AGN) in a cash and stock transaction valued at $63 billion. And Tuesday, almost a year after the news first broke, the pharma giant finally cleared the last of the regulatory hurdles involved when it received th...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Optimism over the economy's reopening appears to be supporting stock prices and the oil rally, as S&P 500 futures rose anothe...

DUBLIN , May 6, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) (" A...

AbbVie's (NYSE: ABBV ) proposed $63B acquisition of Allergan (NYSE: AGN ) has received clearance from the Federal Trade Commission, the final antitrust approval needed to complete the deal, the companies say. More news on: AbbVie Inc., Allergan plc, AstraZeneca PLC, Healthcare stocks new...

NORTH CHICAGO , Ill. and DUBLIN, May 5, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. Federal Trade Commission (FTC) has accep...

The FDA approves Galderma's Restylane Kysse, a hyaluronic acid filler, for lip augmentation and correction of upper perioral rhytids (wrinkles around the upper lip) in adults at least 21 years old. More news on: Allergan plc, Evolus, Inc., Revance Therapeutics, Inc., Healthcare stocks ne...

Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...

AbbVie 's (NYSE: ABBV) share price has been hit pretty hard this year by the COVID-19 pandemic. But its underlying business hasn't. The big drugmaker announced its first-quarter results before the market opened on Friday. AbbVie easily beat Wall Street's revenue and earnings estimates, deliv...

Introduction Agile Therapeutics (NASDAQ: AGRX ) is a women’s healthcare company focused on patch-based contraceptive options. Their lead product, Twirla, is a once-a-week contraceptive patch containing a combined dose of levonorgestrel and ethinyl estradiol. Twirla was recently appr...

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has re...